Abstract | BACKGROUND: METHODS: RESULTS: HDAC1 and HDAC2 are overexpressed in primary rhabdoid tumors and rhabdoid tumor cell lines. Targeting HDACs in rhabdoid tumors induces cell cycle arrest and apoptosis. On the other hand HDAC inhibition induces deregulated gene programs (MYCC-, RB program and the stem cell program) in rhabdoid tumors. These programs are in general associated with cell cycle progression. Targeting these activated pro-proliferative genes by combined approaches of HDAC-inhibitors plus fenretinide, which inhibits cyclinD1, exhibit strong synergistic effects on induction of apoptosis. Furthermore, HDAC inhibition sensitizes rhabdoid tumor cell lines to cell death induced by chemotherapy. CONCLUSION:
|
Authors | Kornelius Kerl, David Ries, Rebecca Unland, Christiane Borchert, Natalia Moreno, Martin Hasselblatt, Heribert Jürgens, Marcel Kool, Dennis Görlich, Maria Eveslage, Manfred Jung, Michael Meisterernst, Michael Frühwald |
Journal | BMC cancer
(BMC Cancer)
Vol. 13
Pg. 286
(Jun 13 2013)
ISSN: 1471-2407 [Electronic] England |
PMID | 23764045
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Histone Deacetylase Inhibitors
- Hydroxamic Acids
- Fenretinide
- Vorinostat
- Doxorubicin
- Histone Deacetylases
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Cell Line, Tumor
- Doxorubicin
(administration & dosage)
- Drug Synergism
- Fenretinide
(administration & dosage)
- Histone Deacetylase Inhibitors
(administration & dosage)
- Histone Deacetylases
(metabolism)
- Humans
- Hydroxamic Acids
(administration & dosage)
- Oligonucleotide Array Sequence Analysis
- Real-Time Polymerase Chain Reaction
- Rhabdoid Tumor
(metabolism, pathology)
- Vorinostat
|